Game-Changing Breast Cancer Research
Research to better diagnose and treat breast cancer is one of our Center's priorities. We've prepared information for you on WHRY-funded studies that advanced and continue to propel improvements in dealing with this disease.
Ultrasound to Supplement Mammography
- Dr. Regina Hooley's research is at the forefront of a national debate on using ultrasound screening to supplement mammography. Can supplemental ultrasound screening benefit women with dense breast tissue? Click here to learn more.
The Human Immune System's Role
- Dr. Joann Sweasy is developing a model of breast cancer that fills a "missing link" by including the human immune system - and is pursuing creation of individual models of a patient's tumor and immune system - "personalized" medicine for breast cancer. Click here for more about her work.
Turning Lupus Against Cancer
- In an unexpected discovery, Dr. Peter Glazer found that a type of antibody that causes harm in lupus patients can kill cancer cells - with particularly powerful tumor-destroying capacity against breast and ovarian cancer cells with BRCA mutations. He is working to translate his discovery into new cancer treatments. Click here for more about his research.
Gene Mutations and Recurrence
- One of our earliest studies, by Dr. Bruce Haffty, revealed that genetic BRCA markers predict a vulnerability to breast cancer recurrence, and continues to inform clinical decisions today. Click here for more about this study.
Distinguishing Innocuous from Harmful Variations
- Widely available tests for BRCA mutations increasingly are showing thousands of variations with risks that have not been characterized - leaving patients no clear options. Dr. Ryan Jensen is now developing a rapid way to distinguish between innocuous and harmful genetic variations to guide decisions after genetic tests. Click here for more about his ongoing study.